Fund Mojo help you discover the best fund managers, funds, and related information

Fund Intelligence | Best Managers | RYCFX Insights | RYCFX Score | RYCFX Performance | RYCFX News | RYCFX Allocation | RYCFX Holdings Change

Rydex Biotechnology C Fund (RYCFX)

Fund performance review and position details on Rydex Biotechnology C Fund (RYCFX)

    Last Trade: $ on , Change: (0%)

Rydex Biotechnology C Fund (RYCFX) HighlightRydex Biotechnology C Fund (RYCFX) Fund Summary

Rydex Biotechnology C Fund (RYCFX) statistics as of May 30, 2016

Category: Health
Fund Family: Rydex Funds
Net Asset: $367.24M
Yield: 0%
Year-to-Date Return: -16.37%
Morningstar rating: 2

 

Rydex Biotechnology C Fund (RYCFX) CostRydex Biotechnology C Fund (RYCFX) Cost

Rydex Biotechnology C Fund (RYCFX) various investment related cost

Initial Investment: 2,500
Total Expense Ratio (Health average): 2.33% (1.32%)
Max Front End Sales Load: 0%
Max Back End Sales Load: 1.00%
Annual Holdings Turnover: 107.00%

 

Rydex Biotechnology C Fund (RYCFX) PerformanceRydex Biotechnology C Fund (RYCFX) Performance

Most current Rydex Biotechnology C Fund (RYCFX) Performance

1-month Performance (Health category median performance): 4.53% (2.65%)
3-month Performance (Health category median performance): 11.46% (9.42%)
1 Year Performance (Health category median performance): -25.55% (-12.93%)
3 Year Performance (Health category median performance): 12.05% (15.21%)
5 Year Performance (Health category median performance): 17.74% (16.08%)
Number of Years of positive return: 11 years
Number of Years of negative return: 3 years
3 year Alpha (Health category average): 8.26 (10.57)
3 year Beta (Health category average): 1.16 (0.9)
3 year Sharpe Ratio: 0.56
3 year Treynor: 10.32

Rydex Biotechnology C Fund (RYCFX) topholdingTop Stock Holdings in Rydex Biotechnology C Fund (RYCFX)

See stock holding change map for more historic information

StockWeightingPrice change (15 mins delay)
Amgen Inc.5.82%0.00%
Gilead Sciences, Inc.5.57%0.00%
AbbVie Inc. Common Stock5.33%0.00%
Celgene Corporation4.78%0.00%
Biogen Inc.4.22%0.00%
Regeneron Pharmaceuticals, Inc.3.27%0.00%
Alexion Pharmaceuticals, Inc.3.06%0.00%
Baxalta Incorporated Common Sto2.86%0.00%
Vertex Pharmaceuticals Incorpor2.46%0.00%
Mylan N.V.2.24%0.00%
*Note: The price change will reset to 0 after the midnight

 

Rydex Biotechnology C Fund (RYCFX) Portfolio AllocationRydex Biotechnology C Fund (RYCFX) Fund Portfolio Allocation

Rydex Biotechnology C Fund (RYCFX) Fund Portfolio Allocation data as of 04/2016

Stock98.85%
Bond0%
Cash1.15%
Other0%

 

Rydex Biotechnology C Fund (RYCFX) CompareCompare with other Health category mutual funds

Below are some additional Health mutual funds generated out of our database

Fund1 Year3 year5 year
Rydex Biotechnology C-25.5512.0517.74
Fidelity Advisor Health Care A (FACDX)-13.4918.7717.80 Compare
Hartford Healthcare A (HGHAX)-7.8017.3816.39 Compare
Janus Global Life Sciences T (JAGLX)-15.8319.3919.37 Compare

See top fund managers for Health Category Funds

 

Rydex Biotechnology C Fund (RYCFX) PerformanceOther Financial Data Web Sites on Rydex Biotechnology C Fund (RYCFX)

Addition research sites for Rydex Biotechnology C Fund (RYCFX)

 

Rydex Biotechnology C Fund (RYCFX) Related ResourcesSee more information on Rydex Biotechnology C (RYCFX) Fund

Popular pages on Rydex Biotechnology C (RYCFX) Fund

Fund Mojo Newsletter

Fund Mojo on Facebook Follow FundMojo on Twitter Fund Update